TCD Pharma

About TCD Pharma

TCD Pharma, established in 2005, is a biotechnology company dedicated to the field of Oncology. The company focuses on developing innovative therapies that address unmet medical needs in cancer treatment. TCD Pharma's flagship product, TCD-717, is currently in clinical trials, showcasing its commitment to advancing oncology therapeutics. The company operates primarily in the biotech and pharmaceutical markets, serving healthcare providers and patients in need of advanced cancer treatments.

TCD Pharma employs a business model centered around in-licensing and strategic partnerships. By collaborating with premier Contract Research Organizations (CROs) and leveraging external resources, the company aims to minimize risks and reduce costs associated with drug development. This approach positions TCD Pharma as a preferred partner for oncology drug discovery and development opportunities in Spain.

The company's strong management team and strategic alliances enable it to stay at the forefront of oncology research, making significant strides in the fight against cancer. TCD Pharma generates revenue through the development and eventual commercialization of its oncology therapies, as well as through partnerships and licensing agreements.